<?xml version='1.0' encoding='utf-8'?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>The Arising Signal</title>
    <link>https://arisinghealthx.com/podcast/</link>
    <description>The Arising’s reporting on longevity, medicine, and the business of health, in audio.</description>
    <language>en-US</language>
    <itunes:author>Arising Health</itunes:author>
    <atom:link href="https://arisinghealthx.com/podcast/feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <title>The difference between knowing and knowing what to do</title>
      <link>https://arisinghealthx.com/podcast/episodes/2026-11-18/</link>
      <description>Six stories from the November 18 edition ask what a finding actually changes: a blood test that can guide treatment for some advanced breast cancers, a blood marker that helps estimate cognitive risk, a trial of eating windows and liver fat, supervised exercise after 60, plaque-measuring software, and a Medicare pilot that ties payment to outcomes. This episode uses an AI-generated version of John Griffin’s voice.</description>
      <itunes:duration>634</itunes:duration>
      <guid isPermaLink="true">https://arisinghealthx.com/podcast/episodes/2026-11-18/</guid>
      <pubDate>Wed, 18 Nov 2026 16:08:21 +0000</pubDate>
      <enclosure url="https://arisinghealthx.com/podcast/audio/2026-11-18.m4a" length="6735924" type="audio/mp4"/>
    </item>
    <item>
      <title>What a number can tell you, and what it can’t</title>
      <link>https://arisinghealthx.com/podcast/episodes/2026-11-16/</link>
      <description>John Griffin revisits what the November 16 reporting can and can’t tell us: postwar sugar rationing and biological-age estimates, shingles vaccination and dementia research, measuring perimenopause symptoms, protein and health, and a once-weekly HIV treatment trial. This episode uses an AI-generated version of John Griffin’s voice.</description>
      <itunes:duration>986</itunes:duration>
      <guid isPermaLink="true">https://arisinghealthx.com/podcast/episodes/2026-11-16/</guid>
      <pubDate>Mon, 16 Nov 2026 00:00:00 -0600</pubDate>
      <enclosure url="https://arisinghealthx.com/podcast/audio/2026-11-16-r2.m4a" length="9221848" type="audio/mp4"/>
    </item>
    <item>
      <title>Hormone therapy and heart risk</title>
      <link>https://arisinghealthx.com/podcast/episodes/2026-11-03/</link>
      <description>Sarah and Michael open with a study of hormone therapy in midlife. They also discuss mitochondrial replacement in fertility clinics, a liver fibrosis trial, and investment in senior housing.</description>
      <itunes:duration>1641</itunes:duration>
      <guid isPermaLink="true">https://arisinghealthx.com/podcast/episodes/2026-11-03/</guid>
      <pubDate>Tue, 03 Nov 2026 00:00:00 -0600</pubDate>
      <enclosure url="https://arisinghealthx.com/podcast/audio/2026-11-03.m4a" length="8120164" type="audio/mp4"/>
    </item>
    <item>
      <title>What do slow waves during REM sleep tell us?</title>
      <link>https://arisinghealthx.com/podcast/episodes/2026-11-02/</link>
      <description>Sleep researchers are finding unexpected patterns in REM sleep as people age. Also in this edition: a heart valve designed for growing children, biological age estimates, and changes in Medicare Advantage.</description>
      <itunes:duration>1132</itunes:duration>
      <guid isPermaLink="true">https://arisinghealthx.com/podcast/episodes/2026-11-02/</guid>
      <pubDate>Mon, 02 Nov 2026 00:00:00 -0600</pubDate>
      <enclosure url="https://arisinghealthx.com/podcast/audio/2026-11-02.m4a" length="5577698" type="audio/mp4"/>
    </item>
    <item>
      <title>Remission in type 2 diabetes</title>
      <link>https://arisinghealthx.com/podcast/episodes/2026-10-31/</link>
      <description>The hosts discuss the RESET trial in younger adults with type 2 diabetes, a small trial in liver fibrosis, and changes to estrogen patch labeling.</description>
      <itunes:duration>965</itunes:duration>
      <guid isPermaLink="true">https://arisinghealthx.com/podcast/episodes/2026-10-31/</guid>
      <pubDate>Sat, 31 Oct 2026 00:00:00 -0500</pubDate>
      <enclosure url="https://arisinghealthx.com/podcast/audio/2026-10-31.m4a" length="4747302" type="audio/mp4"/>
    </item>
    <item>
      <title>A pill for sleep apnea?</title>
      <link>https://arisinghealthx.com/podcast/episodes/2026-10-28/</link>
      <description>An investigational pill for sleep apnea leads this edition. Sarah and Michael also cover a gene-editing trial, blood pressure medication, and what happens after people stop taking tirzepatide.</description>
      <itunes:duration>634</itunes:duration>
      <guid isPermaLink="true">https://arisinghealthx.com/podcast/episodes/2026-10-28/</guid>
      <pubDate>Wed, 28 Oct 2026 00:00:00 -0500</pubDate>
      <enclosure url="https://arisinghealthx.com/podcast/audio/2026-10-28.m4a" length="2631396" type="audio/mp4"/>
    </item>
    <item>
      <title>An early glaucoma trial</title>
      <link>https://arisinghealthx.com/podcast/episodes/2026-10-27/</link>
      <description>What can researchers learn from the first three patients in a reprogramming trial? The hosts also discuss a melanoma vaccine, bone density during weight loss, and an Alzheimer’s trial.</description>
      <itunes:duration>660</itunes:duration>
      <guid isPermaLink="true">https://arisinghealthx.com/podcast/episodes/2026-10-27/</guid>
      <pubDate>Tue, 27 Oct 2026 00:00:00 -0500</pubDate>
      <enclosure url="https://arisinghealthx.com/podcast/audio/2026-10-27.m4a" length="3244567" type="audio/mp4"/>
    </item>
  </channel>
</rss>
